HUYA Bioscience International® leads the facilitation and acceleration of global advancement for new biopharmaceutical product possibilities originating in China. Extensive partnerships are formed with Chinese biopharmaceutical, academic, and commercial institutions to hasten development and add value in international markets for Chinese-origin product prospects. With the most comprehensive portfolio of Chinese compounds spanning all medical domains, HUYABIO has become the preferred partner for optimizing the innovation value of biopharmaceuticals in China. HUYABIO has establishments in the United States, Japan, South Korea, and eight strategic locations.